Home » Archive by Category


BioNano Raises $53M to Identify “Structural Variations” in Genome

November 20, 2014 – 5:44 pm | Edit Post

[Corrected 11/24/14, 12 pm. See below.] San Diego-based BioNano Genomics, which has taken a fundamentally different approach to analyzing the genome, says today it has closed on $53 million in Series…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More

November 20, 2014 – 2:21 pm | Edit Post

Snow? What snow? The only thing piling up at astonishing rates on the West Coast this week is biotech news. Up in Seattle, the Fred Hutchinson Cancer Research Center has unveiled its new president,…

[[Click headline to continue reading.]]

Breaking Bottlenecks, Opening the Floodgates to Genomic Data

November 18, 2014 – 4:00 am | Edit Post

There is a major transformational step underway for managing the growing amount of human genomic data. To date, the focus has been on amassing databanks of genomes and then developing new tools to…

[[Click headline to continue reading.]]

New Study Shows How ZMapp Binds to Ebola, Ways to Boost Potency

November 17, 2014 – 2:18 pm | Edit Post

Scientists at The Scripps Research Institute have produced the first 3-D image of how the ZMapp drug developed by San Diego’s Mapp Biopharmaceutical binds to the Ebola virus, providing new insights…
[[Click headline to continue reading.]]

New Research Could (Finally) Remove RNAi’s Commercial Limitations

November 17, 2014 – 9:05 am | Edit Post

[Corrected 11/17/14, 12:30pm. See below.] If nothing else, the acronym RNAi, which stands for ribonucleic acid interference, should be familiar to biotech observers as something that won two…

[[Click headline to continue reading.]]

Device Maker Says Ebola Patient Recovered After Blood Filtration

November 14, 2014 – 9:10 am | Edit Post

As the global death toll from the current Ebola outbreak officially hit 5,147 this week, a San Diego medical device company is reporting promising findings in the treatment of one infected patient….

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Intarcia, Dendreon, Amgen, Doudna & More

November 13, 2014 – 12:16 pm | Edit Post

[Corrected 11/13/14, 5:40 pm. See below.] West Coast spotlights this week are on new ways to fight disease. Some are close to getting to market: Amgen announced late-stage development and regulatory…

[[Click headline to continue reading.]]

With Wires and Electrodes, Tara Bio Builds a Heart on a Chip

November 12, 2014 – 4:28 am | Edit Post

It’s been pretty clear for some time that there’s a big need to improve the efficiency of drug R&D. By industry’s count, drugs cost over $1 billion to develop, and most of them fail. A big…
[[Click headline to continue reading.]]

Lowering the Cost of Failure in Biopharmaceuticals

November 11, 2014 – 1:00 am | Edit Post

In any business, projects fail, but in biopharmaceuticals, the consequences of failure are especially damaging. Projects in the industry tend to be long and expensive—from clinical trials to…
[[Click headline to continue reading.]]

DMI Diagnostic Device Wins Grand Prize in Nokia Sensing XPrize

November 10, 2014 – 7:00 am | Edit Post

The XPrize Foundation returned to San Diego today to announce that a team led by Eugene Y. Chan of the DNA Medicine Institute (DMI) in Cambridge, MA, is the winner of the second $525,000 grand prize…

[[Click headline to continue reading.]]